Hereditary Breast and Ovarian Cancer Syndrome
📧 Sign up to get email alerts when something new happens for Hereditary Breast and Ovarian Cancer Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Northwestern University is conducting a specimen and data study for ovarian cancer early detection and prevention. The trial is currently re…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: MiniLap Vs Standard Laparoscopy in Prophylactic Bilateral Salpingo-oophorectomy in BRCA-Mutated Patients [NA]
Clinical trial comparing MiniLap versus standard laparoscopy for prophylactic bilateral salpingo-oophorectomy in BRCA mutation carriers; rec…
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland
This update describes a Swiss clinical trial at the University of Basel evaluating cascade genetic testing for hereditary breast and ovarian…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Genetics and Heart Health After Cancer Therapy
This completed clinical trial update examines how genetics influence heart health after cancer therapy, including BRCA1/BRCA2-related breast…
-
CLINICAL_TRIALS withdrawal · 2024-08-21Clinical Trial Update: Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199
The NCT01445275 trial on the cost of cancer risk management in women at elevated genetic risk for ovarian cancer has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS guidance · 2024-07-09Clinical Trial Update: Direct Information to At-risk Relatives [NA]
Clinical trial update about providing direct information to at-risk relatives for hereditary cancer syndromes.
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation [Phase 3]
A Phase 3 trial evaluating letrozole for preventing breast cancer in postmenopausal women who carry BRCA1 or BRCA2 mutations has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: BRCA1/2 and Effect of Mifepristone on the Breast [Phase 2]
Phase 2 trial investigating mifepristone in women with BRCA1/2 mutations (breast cancer susceptibility).
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries [Phase 2]
Phase 2 trial evaluating zoledronate versus observation for maintaining bone mineral density in patients undergoing surgery to remove both o…
-
CLINICAL_TRIALS research · 2019-02-07Clinical Trial Update: Genetic Risk: Whether, When, and How to Tell Adolescents
A completed Johns Hopkins clinical trial examining when and how to communicate genetic risk information to adolescents for Huntington's dise…
-
CLINICAL_TRIALS trial_result · 2018-09-07Clinical Trial Update: Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers [Phase 3]
Phase 3 clinical trial update for an IBSR program in BRCA1/2 mutation carriers with hereditary breast and ovarian cancer syndrome.
-
CLINICAL_TRIALS research · 2018-05-07Clinical Trial Update: Management of Women With BRCA1/2 Mutation
This clinical trial update covers management strategies for women with BRCA1/2 mutations. The study status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2018-04-20Clinical Trial Update: Identification and Referral of Women at Risk for Hereditary Breast/Ovarian Cancer
The document reports a completed clinical trial evaluating methods to identify and refer women at risk for hereditary breast and ovarian can…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age Children [Phase 3]
A Phase 3 trial evaluated whether adding a decision guide to standard genetic counseling improves communication between mothers undergoing B…
-
CLINICAL_TRIALS withdrawal · 2016-01-25Clinical Trial Update: A Trial of the ForeCYTE Breast Aspirator for Cytological Testing of Nipple Aspirate Fluid in Women 30-55 Years Old [Phase 3]
A Phase 3 trial evaluating the ForeCYTE Breast Aspirator for cytological testing of nipple aspirate fluid in women aged 30-55 has been withd…
-
CLINICAL_TRIALS trial_result · 2015-09-29Clinical Trial Update: Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study [Phase 4]
Phase 4 pilot study comparing Protexa versus TiLoopBra for immediate breast reconstruction in breast cancer patients; the study status is co…
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer [Phase 1]
Phase 1 trial evaluating veliparib with carboplatin and paclitaxel in adults with advanced solid tumors has completed. The study included BR…
-
CLINICAL_TRIALS research · 2014-06-06Clinical Trial Update: Outcomes After Perforator Flap Reconstruction for Breast Reconstruction and/or Lymphedema Treatment
Clinical trial update on outcomes after perforator flap reconstruction for breast reconstruction and/or lymphedema treatment, sponsored by t…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers [Phase 2]
Phase 2 trial evaluating an Inquiry Based Stress Reduction program for BRCA1/2 mutation carriers with hereditary breast and ovarian cancer s…
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer [Phase 2]
Phase 2 trial comparing carboplatin versus docetaxel in women with metastatic BRCA1/BRCA2-mutated breast cancer; the study has completed.
-
CLINICAL_TRIALS research · 2013-07-25Clinical Trial Update: Transformation Potential of E2 Exposed Breast Cancer Susceptibility Gene Mutation Heterozygous Epithelial Breast Cells
This clinical trial update examines whether exposure to estradiol (E2) can promote transformation in epithelial cells heterozygous for BRCA1…
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: Telemedicine vs. Face-to-Face Cancer Genetic Counseling [NA]
The study comparing telemedicine and face-to-face genetic counseling for people at risk of hereditary breast/ovarian cancer and Lynch syndro…
-
CLINICAL_TRIALS trial_result · 2011-04-13Clinical Trial Update: Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer [Phase 2]
A Phase 2 trial evaluating arzoxifene or tamoxifen for breast cancer prevention in high-risk premenopausal women has completed. The study wa…